Ticker Tape by TradingView
Since its start in 2014, CannTrust has led the Canadian market in producing consistent products.
Moreover, the company supports ongoing patient education about medical cannabis and is responsible to make it easier for patients to use it. It also has a compassionate use program to support patients with financial needs.For more information on CannTrust (TRST:TSX) please fill out the form below.
A licensed cannabis producer, CannTrust is bringing more than 40 years of pharmacy & healthcare experience to cannabis industry.
Now the company is operating the recently completed 250,000 sq. ft. facility as well as the phase One redevelopment of its 450,000 sq. ft. Niagara Perpetual Harvest Facility.
The 200,000 sq. ft. is expected to be operational in the third quarter. The projected 600,000 sq. ft. greenhouse expansion has already begun. It is the manufacturing centre of excellence in Vaughan, Ontario.
Furthermore, the company is contributing to the growing body of evidence-based research. The product development team works along with their exclusive global pharma partner, Apotex Inc., which are innovating and developing products.